It is unconscionable for Health Canada to have ignored the advice of pharmaceutical makers and allowed inordinate delays in administering second doses of COVID-19 vaccines.
Two more studies have come my way, added to a British one I wrote about last week, that underscore the danger to lives of Canada’s reckless procurement failure compounded by the world’s only federally approved dosage rationing of four months.
